# Bayer CropScience Ltd (BAYERCROP)
> Exchange: NSE | Sector:  | ISIN: 

## Price
Current Price: ₹4342.4
Day Change: +0.44%
52W High: ₹6511
52W Low: ₹4273
Market Cap: ₹19,516 Cr

## Valuation
P/E: 29.11
P/B: 6.25
EPS: ₹149.16
Book Value: ₹695.07
Dividend Yield: 2.89%

## Returns
1Y Return: -5.1%

## Profitability
ROE: 0%
ROCE: 38.75%
Debt/Equity: 0.03
Revenue Growth: 4.7%
Profit Growth: 179.8%
EBITDA Margin: 14.01%
Operating Margin: 9.25%

## About
Bayer CropScience Ltd is a listed Indian business company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Unknown
Industry: Unknown
Sub Industry: Unknown

## Business Model
Overview: Bayer CropScience Ltd makes money through Core products and services, Customer and channel-led sales, Ancillary operating income in its operating segment. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within its sector.
Source: Derived from stock data
Revenue Streams:
- Core products and services
- Customer and channel-led sales
- Ancillary operating income
Operating Model:
- Converts operating assets, distribution reach, and customer demand into revenue across its chosen markets.
- Scale, margins, working capital, capital allocation, and competitive intensity drive shareholder returns.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-22T07:24:02.386Z
Price History Updated: 2026-05-22T07:24:52.057Z
Latest Price History Date: 2026-05-21
Technicals Updated: 2026-05-22T07:24:52.057Z
Quant Updated: 2026-05-22T07:24:52.057Z
Sentiment Updated: 2026-05-22T07:24:52.057Z
Financials Status: current
Financials Updated: 2026-05-22T07:24:53.503Z
Financials Last Attempt: 2026-05-22T07:24:53.503Z
Financials Provider Tried: database
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY22)
Revenue: ₹4576.7 Cr
Operating Profit: ₹760.3 Cr (OPM 16.61%)
Net Profit: ₹645.3 Cr
Tax: ₹201.5 Cr

## Annual P&L History
FY22: Rev ₹4576.7Cr | PAT ₹645.3Cr | OPM 16.61%
FY23: Rev ₹4944.9Cr | PAT ₹758.2Cr | OPM 17.39%
FY24: Rev ₹4892.1Cr | PAT ₹740.5Cr | OPM 18.57%

## Balance Sheet (FY22)
Total Assets: ₹4352.9 Cr
Total Liabilities: ₹1828.6 Cr
Borrowings: ₹86.4 Cr
Cash: ₹780.9 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Simon-Thorsten  Wiebusch, Vice Chairman, MD & CEO
- Vinit Rajesh Jindal, Whole-Time Executive Director & CFO
- Bharati Ratan Shetty, Company Secretary & Compliance Officer
- Shweta  Rai, Country Division Head of the Pharmaceutical Division
- Dinesh S. Bapat, Country Group Mngr of Environmental Science for India, Sri Lanka & for Nepal

---
Source: rupiya.io/stocks/bayercrop
Disclaimer: For research and education only. Not investment advice.